Evidence map›Paper›PMID 27425845›Full record

ArticleAging2016

Cyclin A2 promotes DNA repair in the brain during both development and aging.

Patrick E Gygli, Joshua C Chang, Hamza N Gokozan, Fay P Catacutan, Theresa A Schmidt, Behiye Kaya, Mustafa Goksel, Faisal S Baig, Shannon Chen, Amelie Griveau and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. The mStem cell research & therapy · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Patrick E GygliDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Joshua C ChangMathematical Biosciences Institute, The Ohio State University, Columbus, OH 43210, USA.
Hamza N GokozanDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Fay P CatacutanDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Theresa A SchmidtDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Behiye KayaDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Mustafa GokselDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Faisal S BaigDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Shannon ChenDepartment of Neuroscience, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Amelie GriveauDepartment of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA 94143, USA.
Wojciech MichowskiDepartment of Genetics, Harvard Medical School and Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
Michael WongDepartment of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA 94143, USA.
Kamalakannan PalanichamyDepartment of Radiation Oncology, The Ohio State University College of Medicine. Columbus, OH 43210, USA.
Piotr SicinskiDepartment of Genetics, Harvard Medical School and Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
Randy J NelsonDepartment of Neuroscience, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Catherine CzeislerDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
José J OteroDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
The Ohio State University · USUniversity of California, San Francisco · USDana-Farber Cancer Institute · USHarvard University · US

Funding

The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Tumor Cell Biology Training ProgramT32CA009361 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRAY, NATHANAEL SCHIANDER · 1985 to 2015
$8.9M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
Ohio State Neuroscience Centr CoreP30NS045758 · NINDS · OHIO STATE UNIVERSITY · PI OBRIETAN, KARL H · 2004 to 2015
$7.7M
Cyclin A Function in Stem Cells and in NeoplasiaR01CA132740 · NCI · DANA-FARBER CANCER INST · PI SICINSKI, PETER · 2008 to 2017
$4.4M
Mechanisms of Congenital HypoventilationR01HL132355 · NHLBI · OHIO STATE UNIVERSITY · PI CZEISLER, CATHERINE, OTERO, JOSE JAVIER · 2016 to 2020
$2.5M
NCATS NIH HHS UL1 TR000090NCATS NIH HHS UL1 TR001070NCI NIH HHS R01 CA132740NCI NIH HHS T32 CA009361NHLBI NIH HHS R01 HL132355NINDS NIH HHS P30 NS045758
6 · The paper itself

Abstract

Various stem cell niches of the brain have differential requirements for Cyclin A2. Cyclin A2 loss results in marked cerebellar dysmorphia, whereas forebrain growth is retarded during early embryonic development yet achieves normal size at birth. To understand the differential requirements of distinct brain regions for Cyclin A2, we utilized neuroanatomical, transgenic mouse, and mathematical modeling techniques to generate testable hypotheses that provide insight into how Cyclin A2 loss results in compensatory forebrain growth during late embryonic development. Using unbiased measurements of the forebrain stem cell niche, we parameterized a mathematical model whereby logistic growth instructs progenitor cells as to the cell-types of their progeny. Our data was consistent with prior findings that progenitors proliferate along an auto-inhibitory growth curve. The growth retardation inCCNA2-null brains corresponded to cell cycle lengthening, imposing a developmental delay. We hypothesized that Cyclin A2 regulates DNA repair and that CCNA2-null progenitors thus experienced lengthened cell cycle. We demonstrate that CCNA2-null progenitors suffer abnormal DNA repair, and implicate Cyclin A2 in double-strand break repair. Cyclin A2's DNA repair functions are conserved among cell lines, neural progenitors, and hippocampal neurons. We further demonstrate that neuronal CCNA2 ablation results in learning and memory deficits in aged mice.

Indexed as

AgingAnimalsBehavior, AnimalBrainCell CycleConditioning, PsychologicalCyclin A2DNA RepairHand StrengthMiceMice, TransgenicModels, BiologicalMotor SkillsNeuronsSocial BehaviorStem Cell NicheCyclin A2Cyclin A2DNA repairmathematical modelingneural stem cellsventricular zone/subventricular zone

Identifiers

PMID27425845
PMCPMC4993346
OpenAlexW2506163452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.